Zhengzi Qian

Statistics

Publications

Citations

470

H-Index

Active since

2009

Affiliations

Tianjin Medical University Cancer Institute and Hospital(Current)

Zhengzhou University

Central South University

Fourth Hospital of Hebei Medical University

Nanjing Medical University

Zhengzi Qian is an author at Tianjin Medical University Cancer Institute and Hospital specializing in oncology, cancer immunotherapy, and immunotherapy.

Publications per year

2009–2025

Publications

Synergistic antitumor effects of lenalidomide and rituximab on mantle cell lymphoma in vitro and in vivo

Liang Zhang, Zhengzi Qian, Zhen Cai et al. · American Journal of Hematology · 2009 · 147 citations · Full text

Medicine, Oncology, Pharmacology +17

Co-expression of PD-L1 and p-AKT is associated with poor prognosis in diffuse large B-cell lymphoma via PD-1/PD-L1 axis activating intracellular AKT/mTOR pathway in tumor cells

Ling Dong, Huijuan Lv, Wei Li et al. · Oncotarget · 2016 · 64 citations · Full text

Medicine, Cancer Biology, Oncology +17

Cancer Cell Membrane Camouflaged Mesoporous Silica Nanoparticles Combined with Immune Checkpoint Blockade for Regulating Tumor Microenvironment and Enhancing Antitumor Therapy

Peiqi Zhao, Lihua Qiu, Shiyong Zhou et al. · International Journal of Nanomedicine · 2021 · 58 citations · Full text

Medicine, Immunology, Oncology +17

Risk of second malignant neoplasms after cyclophosphamide-based chemotherapy with or without radiotherapy for non-Hodgkin lymphoma

Yuanlin Xu, Huaqing Wang, Shiyong Zhou et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2012 · 52 citations

Medicine, Oncology, Radiation Oncology +16

Hybrid Membrane Nanovaccines Combined with Immune Checkpoint Blockade to Enhance Cancer Immunotherapy

Peiqi Zhao, Yuanlin Xu, Wei Ji et al. · DOAJ (DOAJ: Directory of Open Access Journals) · 2022 · 31 citations · Full text

Medicine, Immunology, Oncology +17

1–5 of 13